Antimicrobial Agents Practice Questions

Q: Which protease inhibitor has a boosting effect?

Ritonavir. **Explanation:** **Ritonavir** is the correct answer because it is a potent inhibitor of the **Cytochrome P450 3A4 (CYP3A4)** enzyme. In HIV therapy, it is primarily used at low doses as a **pharmacokinetic enhancer (booster)** rather than for its own antiviral activity. By inhibiting the metabolism of other Protease Inhibitors (PIs) like Lopinavir or Darunavir, Ritonavir increases their plasma concentration, prolongs their half-life, and allows for less frequent dosing and improved efficacy. This strategy is known as "Ritonavir-boosted therapy." **Analysis of Incorrect Options:** * **Amprenavir:** This is a protease inhibitor, but it does not possess the significant enzyme-inhibitory properties required to boost other drugs. It is actually the drug that often *requires* boosting. * **Tenofovir:** This is a Nucleotide Reverse Transcriptase Inhibitor (NRTI), not a protease inhibitor. It works by inhibiting the viral reverse transcriptase enzyme. * **Nelfinavir:** This is the only protease inhibitor that is **not** significantly boosted by Ritonavir because it is primarily metabolized by CYP2C19 rather than CYP3A4. **High-Yield Clinical Pearls for NEET-PG:** * **Cobicistat:** Another non-antiviral drug used solely as a booster (pharmacokinetic enhancer) in HAART regimens. * **Adverse Effects of PIs:** Look for "Buffalo Hump" (lipodystrophy), hyperglycemia (insulin resistance), and hyperlipidemia in clinical vignettes. * **Drug Interactions:** Due to CYP3A4 inhibition, Ritonavir has numerous drug-drug interactions (e.g., it can lead to toxicity of statins or benzodiazepines).

Q: Isolated hyperbilirubinemia is classically seen as an adverse effect of which medication?

Rifampin. **Explanation:** **Correct Option: B (Rifampin)** Rifampin is known to cause **isolated hyperbilirubinemia** (predominantly unconjugated) because it competes with bilirubin for uptake into hepatocytes and interferes with its excretion into the bile. Unlike other hepatotoxic drugs, this effect is often transient and occurs without an elevation in serum transaminases (ALT/AST). It is a dose-dependent, pharmacological interference rather than true hepatocellular injury. **Analysis of Incorrect Options:** * **A. Isoniazid (INH):** While INH is hepatotoxic, it typically causes a **hepatocellular pattern** of injury characterized by significant elevations in ALT and AST. It does not cause isolated hyperbilirubinemia. * **C. Pyrazinamide:** This is the most hepatotoxic drug among the first-line ATT. It causes severe liver injury and can trigger gouty arthritis by inhibiting urate excretion, but it does not present with isolated bilirubin elevation. * **D. Capreomycin:** This is a second-line injectable agent (cyclic peptide). Its primary adverse effects are **nephrotoxicity** and **ototoxicity** (similar to aminoglycosides), not hepatotoxicity. **NEET-PG High-Yield Pearls:** * **Rifampin:** Potent inducer of Cytochrome P450 enzymes; causes orange-red discoloration of body fluids (urine, sweat, tears). * **Hepatotoxicity Profile:** Pyrazinamide > Isoniazid > Rifampin (P > I > R). * **Visual Side Effects:** Ethambutol causes optic neuritis (red-green color blindness). * **Clinical Rule:** If a patient on ATT develops jaundice with AST/ALT levels <3 times the upper limit of normal, Rifampin-induced competition for bilirubin uptake is the likely cause.

Q: Which of the following is NOT considered a broad-spectrum antibiotic?

Penicillin G. **Explanation:** The classification of antibiotics is based on their **spectrum of activity**, which refers to the range of microorganisms they can effectively inhibit. **1. Why Penicillin G is the correct answer:** Penicillin G (Benzylpenicillin) is a **narrow-spectrum antibiotic**. It is primarily effective against Gram-positive cocci (e.g., *Streptococci*), some Gram-positive bacilli, and certain Gram-negative cocci (e.g., *Neisseria*). It is highly susceptible to inactivation by beta-lactamases and lacks significant activity against most Gram-negative rods. **2. Why the other options are incorrect:** * **Tetracycline & Doxycycline (Options A & C):** These belong to the Tetracycline class, which are classic **broad-spectrum** agents. They inhibit protein synthesis (30S subunit) and are effective against a wide array of Gram-positive and Gram-negative bacteria, as well as atypical organisms like *Rickettsia*, *Chlamydia*, and *Mycoplasma*. * **Chloramphenicol (Option B):** This is a potent **broad-spectrum** antibiotic that inhibits the 50S ribosomal subunit. It covers a vast range of aerobic and anaerobic bacteria, though its use is limited due to toxicity (e.g., Bone marrow suppression, Gray Baby Syndrome). **High-Yield NEET-PG Pearls:** * **Broad-spectrum definition:** Antibiotics that act on both Gram-positive and Gram-negative bacteria, often including anaerobes or atypicals. * **Extended-spectrum:** This term is often applied to semi-synthetic penicillins like **Amoxicillin** or **Piperacillin**, which have a broader range than Penicillin G but are narrower than Tetracyclines. * **Drug of Choice:** Penicillin G remains the drug of choice for **Syphilis** (*Treponema pallidum*). * **Resistance:** Most *Staphylococci* are now resistant to Penicillin G due to penicillinase production.

Q: Which of the following statements about vancomycin is NOT true?

It acts by inhibiting bacterial protein synthesis.. **Explanation** **1. Why Option B is the Correct Answer (The False Statement):** Vancomycin does **not** inhibit protein synthesis. Instead, it is a **cell wall synthesis inhibitor**. It acts by binding firmly to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide. This binding sterically hinders transglycosylation and transpeptidation, preventing the cross-linking of the peptidoglycan layer. In contrast, protein synthesis inhibitors typically target the 30S or 50S ribosomal subunits (e.g., Aminoglycosides, Macrolides). **2. Analysis of Other Options:** * **Option A:** Vancomycin is indeed **bactericidal** (except against Enterococci, where it is bacteriostatic) and has a narrow spectrum limited to **Gram-positive** organisms (MRSA, *S. epidermidis*, *C. difficile*). Its large molecular size prevents it from crossing the outer membrane of Gram-negative bacteria. * **Option C:** It is a standard alternative for patients allergic to penicillin in cases of **Enterococcal endocarditis**, usually used in combination with an aminoglycoside for synergy. * **Option D:** **Ototoxicity** (deafness) and nephrotoxicity are well-known dose-related adverse effects, especially when vancomycin is administered with other ototoxic drugs like furosemide or gentamicin. **High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** A common infusion-related reaction caused by histamine release (not an allergy). Prevented by slowing the infusion rate. * **Drug of Choice:** For **MRSA** and orally for **Pseudomembranous colitis** (*C. difficile*). * **Resistance Mechanism:** Alteration of the binding site from D-Ala-D-Ala to **D-Ala-D-Lac** (seen in VRSA/VRE). * **Excretion:** Primarily renal; requires dose adjustment in renal failure.

Q: Which of the following antiretroviral drugs is a non-nucleoside reverse transcriptase inhibitor?

Efavirenz. ### Explanation **Correct Answer: B. Efavirenz** **Mechanism and Classification:** Antiretroviral therapy (ART) is classified based on the stage of the HIV life cycle the drugs inhibit [2]. **Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)** like **Efavirenz** bind directly and non-competitively to the enzyme reverse transcriptase at a site distinct from the active site (allosteric site). This induces a conformational change that inhibits the conversion of viral RNA to DNA. Unlike NRTIs, NNRTIs do not require intracellular phosphorylation to become active. **Analysis of Incorrect Options:** * **A. Zidovudine (AZT) & D. Stavudine (d4T):** These are **Nucleoside Reverse Transcriptase Inhibitors (NRTIs)** [3]. They act as competitive inhibitors and "chain terminators" [1]. They are structural analogs of native nucleosides and must be phosphorylated by host cell kinases into triphosphate forms to be active [1]. * **C. Saquinavir:** This is a **Protease Inhibitor (PI)** [3]. It inhibits the viral protease enzyme, preventing the cleavage of precursor polyproteins (gag-pol), which results in the production of immature, non-infectious virions [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Efavirenz Side Effects:** Characteristically causes **CNS side effects** (vivid dreams, nightmares, dizziness, and "hangover" feeling). It is also associated with **teratogenicity** (neural tube defects), though recent guidelines have relaxed restrictions in pregnancy. * **Nevirapine (another NNRTI):** Known for causing severe hepatotoxicity and Stevens-Johnson Syndrome (SJS) [4]. It was historically used to prevent mother-to-child transmission (MTCT). * **Mnemonic for NNRTIs:** "**DEN**" – **D**elavirdine, **E**favirenz, **N**evirapine (and newer agents like Etravirine and Rilpivirine). * **Zidovudine** is specifically known for causing **bone marrow suppression** (anemia/neutropenia).

Q: Which of the following can be given as a single dose antimalarial for P.vivax malaria?

Pyrimethamine + Sulfadoxime. **Explanation:** The combination of **Pyrimethamine and Sulfadoxime (S/P)** is characterized by an exceptionally long half-life (Sulfadoxime ~7–9 days; Pyrimethamine ~4 days). This pharmacological profile allows for **single-dose administration**, ensuring high patient compliance. It acts via sequential blockade of folic acid synthesis, targeting the erythrocytic schizonts of malaria parasites. While primarily used for *P. falciparum*, it is also effective against the erythrocytic stages of *P. vivax*. **Analysis of Incorrect Options:** * **A. Atovaquone + Proguanil:** This combination (Malarone) requires a **3-day course** for treatment or daily administration for prophylaxis. It is not used as a single dose. * **B. Artemisinin:** Artemisinin derivatives (like Artesunate or Artemether) have very short half-lives. When used as monotherapy, they require at least 5–7 days of treatment; in ACT (Artemisinin-based Combination Therapy), they are typically given for **3 days**. * **C. Quinine + Tetracycline:** Quinine has a short half-life and narrow therapeutic index, requiring dosing every 8 hours for **7 days**. Tetracycline also requires a 7-day course. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** S/P inhibits Dihydrofolate Reductase (Pyrimethamine) and Dihydropteroate Synthase (Sulfadoxime). * **Radical Cure:** Note that while S/P treats the blood stage of *P. vivax*, a **14-day course of Primaquine** (or a single dose of **Tafenoquine**) is mandatory to clear the **hypnozoites** (liver stage) and prevent relapse. * **Contraindication:** Avoid S/P in patients with sulfa allergies or severe renal/hepatic failure. It is also avoided in the first trimester of pregnancy due to antifolate effects.

Q: Which of the following is NOT included in the treatment of Mycobacterium avium complex?

Pyrazinamide. **Explanation:** The **Mycobacterium avium complex (MAC)** consists of *M. avium* and *M. intracellulare*. Unlike *Mycobacterium tuberculosis*, MAC is **intrinsically resistant** to most standard first-line antitubercular drugs, most notably **Pyrazinamide**. 1. **Why Pyrazinamide (D) is the correct answer:** Pyrazinamide requires an acidic environment and the enzyme pyrazinamidase to be converted into its active form (pyrazinoic acid). MAC lacks the specific susceptibility mechanisms required for Pyrazinamide to be effective; therefore, it has no role in the treatment of MAC infections. 2. **Why the other options are incorrect:** * **Clarithromycin (B):** Macrolides (Clarithromycin or Azithromycin) are the **cornerstone** of MAC therapy. They inhibit protein synthesis and are essential for both prophylaxis and treatment. * **Rifabutin (C):** This is a rifamycin preferred over Rifampin for MAC because it is more potent against this complex and has fewer drug-drug interactions in HIV patients on HAART. * **Ciprofloxacin (A):** Fluoroquinolones (like Ciprofloxacin or Moxifloxacin) are considered **second-line or adjunctive agents** used in multidrug regimens for macrolide-resistant MAC or disseminated disease. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen for MAC:** Clarithromycin + Ethambutol + Rifabutin. * **Prophylaxis:** In HIV patients with **CD4 counts <50 cells/mm³**, primary prophylaxis with Azithromycin or Clarithromycin is indicated. * **Key Distinction:** Pyrazinamide is only used for *M. tuberculosis*; it is ineffective against almost all Non-Tuberculous Mycobacteria (NTM).

Question 1

What is the most serious adverse effect of ketoconazole?

Accepted Answer

Adrenal insufficiency

Answer

Pellagra-like skin lesion

Answer

Liver injury

Answer

Prostate cancer

Question 2

Which protease inhibitor has a boosting effect?

Accepted Answer

Ritonavir

Answer

Amprenavir

Answer

Tenofovir

Answer

Nelfinavir

Question 3

Isolated hyperbilirubinemia is classically seen as an adverse effect of which medication?

Accepted Answer

Rifampin

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Capreomycin

Question 4

Which of the following is NOT considered a broad-spectrum antibiotic?

Accepted Answer

Penicillin G

Answer

Tetracycline

Answer

Chloramphenicol

Answer

Doxycycline

Question 5

Which among the following is not a beta-lactamase resistant Penicillin?

Accepted Answer

Carbenicillin

Answer

Methicillin

Answer

Nafcillin

Answer

Oxacillin

Question 6

Which of the following statements about vancomycin is NOT true?

Accepted Answer

It acts by inhibiting bacterial protein synthesis.

Answer

It is a bactericidal antibiotic active primarily against gram-positive bacteria.

Answer

It is an alternative to penicillin for enterococcal endocarditis.

Answer

It can cause deafness as a dose-related toxicity.

Question 7

A 65-year-old male with pneumonia has a sputum culture positive for a staphylococcal strain that is 
-lactamase-positive. Which is the best choice of penicillin therapy in this patient?

Accepted Answer

Oxacillin

Answer

Ampicillin

Answer

Ticarcillin

Answer

Penicillin G

Question 8

Which of the following antiretroviral drugs is a non-nucleoside reverse transcriptase inhibitor?

Accepted Answer

Efavirenz

Answer

Zidovudine

Answer

Saquinavir

Answer

Stavudine

Question 9

Which of the following can be given as a single dose antimalarial for P.vivax malaria?

Accepted Answer

Pyrimethamine + Sulfadoxime

Answer

Atovaquone + Proguanil

Answer

Artemisinin

Answer

Quinine + Tetracycline

Question 10

Which of the following is NOT included in the treatment of Mycobacterium avium complex?

Accepted Answer

Pyrazinamide

Answer

Ciprofloxacin

Answer

Clarithromycin

Answer

Rifabutin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?